ConductScience.org, home

Comparison · NCT01925014-2666ce3d

Low-dose CT vs Standard-dose CT: Appendiceal Perforation Rate

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Low-dose CT vs Standard-dose CT: Appendiceal Perforation Rate. Trial comparisons, record NCT01925014-2666ce3d. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01925014-2666ce3d

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.3470.3080.389wilson
Risk in group 20.3120.2750.351wilson
Risk difference, group 1 minus group 20.0353-0.02050.091newcombe hybrid score
Risk ratio, group 1 over group 21.110.9391.32log
Odds ratio, group 1 over group 21.170.9111.51log
Number needed to treat, for one more participant with the outcome on Low-dose CT than on Standard-dose CT28.4from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Low-dose CT2 millisievert182524OG000
Group 2Standard-dose CT8 millisievert or lower176564OG001

Outcome

Type
SECONDARY
Title
Appendiceal Perforation Rate
Description
The percentage of perforated appendicitis among confirmed appendicitis cases.
Time frame
1 week after surgery
Population
Patients confirmed as having appendicitis. Intention-to-treat.

Source ClinicalTrials.gov

Trial

Title
Low vs. Standard Dose CT for Appendicitis Trial
NCT number
NCT01925014
Phases
NA
Conditions
Appendicitis
Interventions
Diagnostic CT with low-dose radiation, Diagnostic CT with standard-dose radiation
Lead sponsor
Kyoung Ho Lee, MD
Results first posted
2019-01-31

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT01925014-2666ce3d